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Abstract
Background: Peptide transporters are membrane proteins that mediate the cellular uptake of di- and tripeptides,
and of peptidomimetic drugs such as β-lactam antibiotics, antiviral drugs and antineoplastic agents. In spite of their
high physiological and pharmaceutical importance, the molecular recognition by these transporters of the amino
acid side chains of short peptides and thus the mechanisms for substrate binding and specificity are far from being
understood.
Results: The X-ray crystal structure of the peptide transporter YePEPT from the bacterium Yersinia enterocolitica
together with functional studies have unveiled the molecular bases for recognition, binding and specificity of
dipeptides with a charged amino acid residue at the N-terminal position. In wild-type YePEPT, the significant
specificity for the dipeptides Asp-Ala and Glu-Ala is defined by electrostatic interaction between the in the structure
identified positively charged Lys314 and the negatively charged amino acid side chain of these dipeptides.
Mutagenesis of Lys314 into the negatively charged residue Glu allowed tuning of the substrate specificity of YePEPT
for the positively charged dipeptide Lys-Ala. Importantly, molecular insights acquired from the prokaryotic peptide
transporter YePEPT combined with mutagenesis and functional uptake studies with human PEPT1 expressed in
Xenopus oocytes also allowed tuning of human PEPT1’s substrate specificity, thus improving our understanding of
substrate recognition and specificity of this physiologically and pharmaceutically important peptide transporter.
Conclusion: This study provides the molecular bases for recognition, binding and specificity of peptide transporters
for dipeptides with a charged amino acid residue at the N-terminal position.
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Background
Peptide transporters from the proton-dependent oligopep-
tide transporter (POT) family [1] are integral membrane
proteins that mediate the cellular uptake of di- and tripep-
tides using energy provided by transmembrane proton gra-
dients. POTs belong to the major facilitator superfamily
(MFS) of secondary active transporters and are found in
all kingdoms of life where they play major roles in nutri-
tion and signaling [2]. In humans the absorption of dietary
peptides and of numerous orally administrated drugs is
mediated by the two peptide transporters PEPT1
(SLC15A1) and PEPT2 (SLC15A2). PEPT1 and PEPT2 are
predominantly expressed in epithelial cells of the small
intestine and kidney, respectively [3]. PEPT1 operates as a
high-capacity, low-affinity transporter with affinities (Km)
and inhibition constants (Ki) ranging from 200 μM to
10 mM depending on the substrate [4]. On the other hand,
PEPT2 is a low-capacity, high-affinity transporter with Km
and Ki values ranging from 5 μM to 500 μM depending on
the substrate [4]. These kinetic properties make PEPT1
and PEPT2 ideal for the promiscuous and more specific
absorption of a broad range of dietary peptides in the small
intestine and in the kidney, respectively. The human
PEPT1 and PEPT2 transporters have become of major
pharmaceutical importance, as they are responsible for the
uptake of β-lactam antibiotics and peptide prodrugs [5].
The first crystal structure of a POT family member,
PepTSo from the bacterium Shewanella oneidensis, was
published in 2011 and revealed a novel occluded con-
formation of an MFS transporter [6]. In the following
years several additional structures of prokaryotic peptide
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transporters were reported: PepTSt from Streptococcus
thermophilus [7, 8]; GkPOT from Geobacillus kaustophilus
[9]; PepTSo2 from Shewanella oneidensis [10, 11]; and
YbgH from Escherichia coli (E. coli) [12]. All these struc-
tures revealed a conserved architecture consisting of 14
transmembrane α-helices (H) with N- and C-terminal six-
helix bundles (H1–H6 and H7–H12) and two additional
transmembrane α-helices (HA and HB) connecting the
two bundles. The structures of GkPOT [9] and PepTSo2
[10] were obtained in complex with alafosfalin, an antibac-
terial phosphono dipeptide, and the structures of PepTSt
[8] and PepTSo2 [11] in complex with di- and tripeptides,
giving first structural insights into the promiscuous sub-
strate recognition of peptide transporters. In spite of the
available structural information several key questions re-
main open. These questions include the molecular bases
for the specific recognition of substrates, such as charged
dipeptides and of the individual side chains in dipeptides,
namely N- versus C-terminal amino acid side chain.
We have solved the X-ray crystal structure of the POT
family member YePEPT from Yersinia enterocolitica at
3 Å resolution. This structure together with structure-
function studies unveiled the molecular basis for recogni-
tion of dipeptides with a charged amino acid side chain at
the N-terminal position by YePEPT. Importantly, struc-
tural and functional insights gained from this prokaryotic
peptide transporter were used to perform specific uptake
experiments with human PEPT1 expressed in Xenopus
oocytes. This knowledge helped to extend our current
understanding of substrate recognition and specificity in
human PEPT1.
Results and discussion
From bacteria to mammals, peptide transporters from the
POT family (also referred to as the peptide transporter
(PTR) family [13]) strongly differ in amino acid sequence
and protein size. However, three small protein stretches
are conserved: the EFxERFxYYG; GxxxADxxxGKxxTIxxx
SxxYxxG (PTR2_1); and FSxFYxAINxGSL (PTR2_2) mo-
tifs [2]. Residues of these three signature motifs, which are
highly conserved in human PEPT1 (hPEPT1) and PEPT2
(hPEPT2), and other higher eukaryotes, are mostly con-
served in YePEPT (Additional file 1: Table S1, see also le-
gend to this table for a short description of the three
conserved motifs). The conserved EFxERFxYYG, PTR2_2
and PTR2_1 motifs are essential for peptide transport
function [2, 14].
For functional and structural studies, the gene of
YePEPT was cloned and the protein overexpressed in
E. coli (Methods).
Functional characterization of YePEPT
Transport function of YePEPT was determined using
the reporter radioligand [3H]Ala-Ala, which displayed a
Km of about 200 μM (Fig. 1a). This Km is comparable to
the determined Kis of hPEPT1 (about 160 μM) and
hPEPT2 (about 100 μM) for Ala-Ala [15]. Competition
experiments with [3H]Ala-Ala in the presence of the
amino acid L-Ala and its di-, tri- and tetrapeptides indi-
cated a clear preference of YePEPT for the dipeptide Ala-
Ala only (Fig. 1b). This is in contrast to hPEPT1 and
hPEPT2, and numerous other POT family members, which
also possess specificity for the tripeptide Ala-Ala-Ala and
other tripeptides [2, 15]. For further characterization of
transport, we studied the requirements of Na+ and H+ as
co-transport ions. The replacement of Na+ by choline
had no effect on the uptake of [3H]Ala-Ala, but the
presence of the proton ionophore carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) caused complete aboli-
tion of transport (Fig. 1b). Thus, and as expected for POT
family members, peptide uptake via YePEPT depends on
the electrochemical proton gradient across the membrane.
The dipeptide binding preference of YePEPT (Fig. 1c)
was addressed as follows: In a systematic manner, one
amino acid in the reporter dipeptide Ala-Ala was re-
placed at a time at both positions, R1 (N-terminal amino
acid) and R2 (C-terminal amino acid), by amino acids of
different chemical properties, namely negatively and
positively charged, and hydrophobic. YePEPT indicated
an important specificity for a dipeptide with a negatively
charged amino acid side chain at the R1 position, that is
for Asp-Ala (Fig. 1c). This was further confirmed by the
determination of the Ki of YePEPT for Asp-Ala (Fig. 1d).
With a Ki of about 80 μM (Asp-Ala), YePEPT had a
clearly higher affinity for a dipeptide with a negatively
charged amino acid side chain at R1 position compared
to Ala-Ala (Ki of about 200 μM; Fig. 1a). To support this
finding and for comparison with Asp-Ala, the affinity of
YePEPT for Glu-Ala was determined, which was about
50 μM (Additional file 2: Figure S1). Considering these
Ki values, YePEPT had a slightly higher affinity for Glu-
Ala compared to Asp-Ala. However, the affinities for
these dipeptides harboring negatively charged residues at
the R1 position and differing by one methylene group in
chain length were not substantially different. Although
not so pronounced as for Asp-Ala and Ala-Ala, YePEPT
also displayed specificity for Ala-Tyr and Tyr-Ala at
comparable levels (Fig. 1c). Such a behavior, that is the
indifference for the position of the large, hydrophobic
side chain of the amino acid residue Tyr in dipeptides,
was also observed for hPEPT1 [16].
Overall structure of YePEPT
The crystal structure of YePEPT was solved at 3 Å reso-
lution by X-ray crystallography (Methods and Table 1).
The quality of the obtained density map can be assessed
in Additional file 3: Figure S2. The structure displays 14
transmembrane helices with H1–H6 and H7–H12
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forming the N- and C-terminal six-helix bundles (Fig. 2,
bundles in red and blue). These two terminal domains are
related by a pseudo-twofold symmetry (particularly distinct
in Fig. 2, bottom) and are representative of the canonical
MFS fold [17]. The two peripheral transmembrane
α-helices HA and HB (Fig. 2, in gold) form a hairpin-like
structure connecting N- and C-terminal bundles, and are
generally found in prokaryotic peptide transporters. The
function of these two linker transmembrane α-helices is
currently unclear. The solved YePEPT crystal structure is
in the inward-open conformation, similar to most pro-
karyotic peptide transporter structures [7–12] (see also
Additional file 4: Figure S3 and its legend for a structural
alignment and RMSD values of YePEPT with other peptide
transporter structures in the inward-open conformation).
This conformational state displays a large central, conical
cavity facing the cytosol (Fig. 2, top; asterisk).
Substrate-binding pocket of YePEPT
At present the structures of the peptide transporters
GkPOT mutant E310Q (GkPOTE310Q) [9] and PepTSt [8]
represent the crystal structures solved in complex with
substrates at the highest resolution, namely GkPOTE310Q
with alafosfalin at 2.40 Å (PDB ID code: 4IKZ) and PepTSt
with the dipeptide Ala-Phe at 2.47 Å (PDB ID code:
4D2C). We made numerous attempts to co-crystallize
YePEPT with substrate, but were not successful. There-
fore, and to identify the putative substrate-binding pocket
of YePEPT, we aligned the crystal structure of YePEPT
with the substrate-bound GkPOTE310Q and PepTSt struc-
tures. This yielded hypothetical models of substrate-bound
YePEPT. Comparison of these models identified the
YePEPT residues located in proximity of the two ligands
(Fig. 3; see also Additional file 5: Figure S4 for a compari-
son of the binding pockets of YePEPT, GkPOTE310Q and
PepTSt). No noteworthy clashes were observed between
the YePEPT structure and the ligands alafosfalin and Ala-
Phe, the closest interatomic distances being 1.8 Å and
1.5 Å, respectively. All amino acid residues in GkPOTE310Q
and PepTSt involved in the binding of the backbone of the
dipeptide analogue alafosfalin and the dipeptide Ala-Phe
were also conserved in YePEPT (see Fig. 3 and Additional
file 5: Figure S4: residues colored in black; and Additional
file 6: Table S2). These conserved amino acid residues
were classified into four groups according to their interac-
tions with the backbones of alafosfalin and Ala-Phe: group
Fig. 1 Functional characterization of YePEPT. a Kinetics of YePEPT-mediated [3H]Ala-Ala uptake in E. coli cells. Uptake of the radioligand in E. coli
cells transformed with the YePEPT construct (YePEPT) and the empty vector (vector; control) is shown. The determined Km is indicated. Error bars
represent SEM from triplicates. One representative experiment from three similar independent experiments is shown. b Co-transport ion and
substrate chain length dependence of uptake: Na+ dependence was assessed by replacing Na+ with choline (−Na+); and H+ dependence by
addition of the proton-ionophore carbonyl cyanide 3-chlorophenylhydrazone (CCCP). Chain length dependence was assessed with L-Ala and the
corresponding di-, tri- and tetrapeptides as competitors (10 mM final concentration). c Substrate specificity of YePEPT by competition assay (2.5 mM
final concentration). Error bars in (b) and (c) represent SEM from at least three independent experiments, each in triplicate. d Ki determination of
YePEPT for Asp-Ala. The determined Ki is indicated (95 % confidence intervals: 46–126 μM). Error bars represent SEM from triplicates. One representative
experiment from three similar independent experiments is shown
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i) Asn344 and Glu420 (N-terminal amino group); group ii)
Tyr35 and Asn163 (carbonyl group); group iii) Tyr35,
Arg38, Tyr73 and Glu312 (phosphonate group); and group
iv) Arg31 and Lys133 (C-terminal carboxyl group) (amino
acid residues indicated for YePEPT; Fig. 3 and Additional
file 6: Table S2). Besides group iii), which specifically inter-
acts with the phosphonate group of alafosfalin, the other
three groups represent the general recognition mode of
the backbone of dipeptides. These interactions of the
transporter with the dipeptide backbone, which are dipep-
tide side chains independent interactions, can be consid-
ered as responsible for the substrate polyspecificity
(promiscuity) observed in most peptide transporters.
A prominent feature of YePEPT is the presence of a
lysine residue (Lys314) close to the above described
binding pocket (Fig. 3). The presence of this positively
charged residue was particularly interesting considering
the high affinity of YePEPT for dipeptides with a nega-
tively charged amino acid at R1 position, namely Asp-
Ala (Fig. 1d) and Glu-Ala (Additional file 2: Figure S1).
A plausible molecular explanation for the observed sub-
strate affinity is an electrostatic interaction between the
negatively charged carboxyl group at the R1 side chains
in Asp-Ala and Glu-Ala, and the positively charged resi-
due Lys314 in YePEPT. Mutagenesis in silico of Ala-Phe
(Fig. 3c,f ) into Asp-Ala, keeping the dipeptide backbone
of Ala-Phe fixed and mutating the side chains, yielded a
hypothetical model of YePEPT with bound Asp-Ala
(Fig. 4a,b). The displayed rotamer of Asp in Asp-Ala fits
best into the YePEPT structure without introducing any
Table 1 Data collection and refinement statistics for YePEPT
Data collection
Beamline X06SA, SLS
Wavelength (Å) 1.00
Space group P212121
Unit cell parameters (Å, °) a = 90.7, b = 101.0, c = 104.2,
α = β = γ = 90
Resolution (Å) 46.30–3.02 (3.18–3.02)
Number of observed reflections 126,940 (18,201)
Number of unique reflections 19,398 (2,737)
Rmerge (%) 5.6 (99.7)
Completeness (%) 99.8 (98.8)
Multiplicity 6.5 (6.6)
I/σI 20.0 (2.0)
CC1/2 (%)
a 99.9 (76.1)
Refinement
Resolution (Å) 46.30–3.02 (3.10–3.02)
Rwork/Rfree (%) 25.71 (36.07)/29.40 (39.11)
B factor (Å2) 105.0
Number of atoms 3,686
RMSD
Bond length (Å) 0.005
Bond angle (°) 0.889
Ramachandran plot (%)
Favored region 97.5
Allowed region 100
Disallowed region 0
Values in parentheses reflect the highest resolution shell. aPercentage of
correlation between intensities from random half data sets. RMSD, root-mean-
square deviation; SLS, Swiss Light Source
Fig. 2 Overall structure of YePEPT. Structure of YePEPT viewed in
the plane of the membrane (top) and from the cytosol (bottom).
The N- and C-terminal six-helix bundles are colored in red and blue,
respectively. The two helices HA and HB connecting the two bundles
are colored in gold. The N- and C-termini are labeled. In the top view
(bottom) the transmembrane helices H1–H12, and HA and HB are
labeled. Parts of the loops connecting H6 and HA, and H8 and H9 that
could not be traced are indicated by broken lines
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clashes. Based on this model, the distance between the
closest oxygen atom (O) of the β-carboxyl group in the
Asp side chain of Asp-Ala and the nitrogen atom (N) of
the ε-amino group in the Lys314 side chain was 4.8 Å
(Fig. 4a). This relatively large distance is not compatible
with a salt bridge. However, adoption of a different rota-
mer of Lys314 upon binding of Asp-Ala would decrease
this distance significantly from 4.8 Å to 2.5 Å, thus
allowing the formation of a salt bridge (Fig. 4b). Such a
salt bridge would neutralize the positive charge on the ε-
amino group of Lys314. But how is this charge stabilized
in the absence of a negatively charged ligand such as
Asp-Ala? To answer this pertinent question, neighboring
residues of Lys314 within a distance of ≤4 Å in the crys-
tal structure were considered and Phe311 was identified
as an interacting partner. The O of the Phe311 carbonyl
group and the N of the ε-amino group of Lys314 are
within hydrogen bonding distance (Fig. 4c). Further-
more, this N is 3.5-4.3 Å away from the carbon atoms of
the phenyl group of Phe311 and thus compatible with a
pi-cation interaction. Therefore, the positive charge of the
ε-amino group of Lys314 is potentially stabilized by two
molecular interactions with Phe311 in the apo structure of
YePEPT. To test this hypothesis, we introduced the muta-
tion F311A (YePEPTF311A) and performed [3H]Ala-Ala
uptake experiments. Clearly, YePEPTF311A was almost not
functional compared with wild-type YePEPT in spite of
comparable expression levels (Fig. 4d). This result sup-
ports the notion that the positively charged ε-amino group
of Lys314 has to be stabilized to preserve peptide trans-
port function. Furthermore, it indicates that the hydrogen
bond between the ε-amino group of Lys314 and the
backbone carbonyl group from the amino acid residue at
position 311, for example Ala in YePEPTF311A, is not
Fig. 3 Substrate-binding pocket of YePEPT. Top view from the cytosol (a) and view from the membrane plane (d) of the substrate-binding pocket
of YePEPT. The areas marked by the black boxes in (a) and (d) are displayed at higher magnification in (b) and (c), and (e) and (f), respectively.
Amino acid residues of YePEPT potentially involved in alafosfalin (in yellow; (b) and (e)) and dipeptide backbone binding (Ala-Phe dipeptide in
green; panels (c) and (f)) are labeled, colored in black and conserved in YePEPT, GkPOTE310Q and PepTSt (see Additional file 6: Table S2 for more
details and groups of conserved amino acid residues involved in alafosfalin and Ala-Phe dipeptide backbone binding). The indicated amino acid
residues of YePEPT were identified by superposition of the YePEPT structure with the ligand-bound peptide transporter structures 4D2C [8] and
4IKZ [9] (PDB ID codes). The distances between the nitrogen atom of Lys314 and the carbon atoms of the N-terminally located methyl groups of
alafosfalin (e) and Ala-Phe (f) are marked, and indicate available space between ligands and Lys314; for example, for accommodation of longer
side chains. The N- and C-terminal six-helix bundles are colored in salmon and cyan, respectively, and helices HA and HB in black. YePEPT
polypeptide chains in (a) and (d) that could not be traced are indicated by broken lines
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sufficient for stabilization. Therefore, the above mentioned
pi-cation interaction seems to be indispensable for charge
stabilization. However, we cannot exclude other effects on
the transport function of YePEPT upon removal of such a
bulky amino acid residue, such as F311. An interaction of
Lys314 with the closely localized Glu312 in YePEPT is im-
probable or weak when considering the distance of 4.9 Å
between the corresponding N and O atoms of these two
residues (Fig. 4a).
The existence in other bacterial peptide transporters of
a Lys residue at the equivalent position of K314 (YePEPT)
in their substrate binding pockets was evaluated. The Phe-
Lys region (Additional file 1: Table S1), which contains
this critical Lys residue, is identical in several members
from the large Enterobacteriaceae family; for example, in
members from the genus Yersinia, Enterobacter and Kleb-
siella. In addition to Enterobacteriaceae, the critical Lys
residue is also present in less conserved Phe-Lys regions
found in other families of the Gammaproteobacteria;
for example, in members from the genus Arenimonas,
Shewanella and Rheinheimera from the families Xantho-
monadaceae, Shewanellaceae and Chromatiaceae.
Tuning the substrate specificity of YePEPT
From the hypothetical model of Asp-Ala bound YePEPT
(Fig. 4), it appears likely that Lys314 is responsible for its
specificity for dipeptides with negatively charged amino
acids at the R1 position. To test this hypothesis, we intro-
duced the mutation K314E (YePEPTK314E) and K314A
(YePEPTK314A) in YePEPT, and repeated the previous com-
petition experiments. The results clearly demonstrated that
the specificity of YePEPT for charged residues could be
tuned (YePEPTK314E) and abolished (YePEPTK314A) in the
corresponding mutants (Fig. 5). In more detail,
YePEPTK314E acquired specificity for dipeptides with a
positively charged amino acid side chain in the R1 pos-
ition (Lys-Ala; Fig. 5a) and lost the specificity for nega-
tively charged amino acids in that position (Asp-Ala;
Fig. 5a). In contrast, YePEPTK314A had no affinity for the
charged dipeptides Lys-Ala and Asp-Ala (Fig. 5b). This
functional data further supports the notion of the involve-
ment of electrostatic interactions between a charged resi-
due at position 314 of YePEPT and a dipeptide with a
charged amino acid side chain at the N-terminal position.
An involvement of Lys314 in proton translocation can
be excluded because the mutants YePEPTK314E and
YePEPTK314A were fully functional (Fig. 5). In contrast to
YePEPT, which has a Lys at position 314, GkPOT and
PepTSt have both a Gly residue at the equivalent position.
Based on the results presented above with YePEPTK314A,
comparable substrate specificities would be expected for
GkPOT and PepTSt. Indeed, GkPOT and PepTSt do not
Fig. 4 Hypothetical model of Asp-Ala bound YePEPT and stabilizing effect of Phe311. a YePEPT structure with a virtually bound Asp-Ala dipeptide
(view from the membrane plane): this dipeptide was built by keeping the dipeptide backbone of Ala-Phe (Fig. 3c,f) fixed and mutating the side chains
of Ala-Phe into Asp-Ala in Pymol [23]. The rotamer of Asp in Asp-Ala does not introduce any clashes with the YePEPT structure. The distances between
the nitrogen atom of Lys314 and the closest oxygen atoms of the carboxyl groups of Asp-Ala (residue at R1 position) and Glu312 are indicated. b The
rotamer of Lys314 found in the crystal structure (magenta) and of the rotamer with the shortest distance to the closest oxygen atom of the carboxyl
group of Asp-Ala (residue at R1 position) is shown (pale green). c In the YePEPT crystal structure, the interactions between Lys314 and the stabilizing
residue Phe311 consist of a hydrogen bond and a pi-cation interaction between the ε-amino group of Lys314, and the carbonyl and phenyl groups of
Phe311, respectively. Amino acid residues of YePEPT potentially involved in dipeptide backbone binding are labeled and colored in black (similar to
Fig. 3). The N- and C-terminal six-helix bundles are colored in salmon and cyan, respectively. d Mutation of the Lys314 stabilizing Phe311 residue into
Ala dramatically reduces the transport function of YePEPT. Expression levels in E. coli of wild-type (wt) and YePEPTF311A (F311A) used for the uptake
experiments were comparable. Error bars in (d) represent SEM from two independent experiments, each in triplicate
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show significant specificity for charged dipeptides, but
rather specificity for hydrophobic dipeptides [7, 9].
Influence of the Q300K mutation in human PEPT1 on
substrate specificity
In contrast to YePEPT, human PEPT1 does not have a
pronounced affinity for dipeptides with a negatively
charged amino acid residue at R1 position; for example,
Asp-Ala (Ki of 320 μM) [18]. Amino acid sequence
alignment of YePEPT, hPEPT1 and hPEPT2 identified a
Gln residue at the position corresponding to Lys314 in
YePEPT (Additional file 1: Table S1, Phe-Lys region).
From this alignment it also appears that hPEPT1 has a
Phe residue at the position corresponding to Phe311 in
YePEPT. The availability of a Phe residue at this critical
position in hPEPT1, which we showed to be essential in
conjunction with Lys314 in YePEPT for transport func-
tion, stimulated us to introduce the mutation Q300K
(hPEPT1Q300K). Comparison of the specificities for se-
lected substrates in wild-type hPEPT1 and hPEPT1Q300K
(Fig. 6) clearly showed that the Q300K mutation induced
affinity for Asp-Ala in hPEPT1Q300K. Furthermore, the
introduction of a positively charged residue in the
binding pocket significantly reduced the specificity of
hPEPT1Q300K for the positively charged dipeptide Lys-
Ala (Fig. 6). In summary, residue 314 in YePEPT corre-
sponds to residue 300 in the binding pocket of hPEPT1.
The residue at this critical position determines substrate
recognition and specificity for dipeptides charged at R1
position via electrostatic interactions.
Conclusions
Negatively charged amino acid side chains at the N-
terminal position of dipeptides are recognized by Lys314
in YePEPT and interact with each other via electrostatic
interactions. Site-directed mutagenesis of Lys314 in
YePEPT and the corresponding residue in human PEPT1
(Gln300) can tune the substrate specificity of these pep-
tide transporters. In summary, the crystal structure of
YePEPT together with structure-function studies have
provided the molecular bases for the recognition, binding
and specificity of charged amino acid residues at the
N-terminal position of dipeptides by peptide transporters
of the POT family.
Fig. 5 Substrate specificity of K314E and K314A YePEPT mutants.
[3H]Ala-Ala uptake competition experiments performed with E. coli
cells expressing (a) K314E and (b) K314A mutants of YePEPT. Error bars
represent SEM from four independent experiments, each in triplicate
Fig. 6 Comparison of substrate specificities of human PEPT1 and
Q300K mutant. [3H]Ala-Ala uptake competition experiments were
performed with Xenopus laevis oocytes expressing (a) wild-type
human PEPT1 (hPEPT1-wt) and (b) the Q300K mutant (hPEPT1-Q300K).
Error bars represent SEM from two independent experiments, each
containing 12 oocytes
Boggavarapu et al. BMC Biology                Page 7 of 10
Methods
Cloning of YePEPT
The gene of the peptide transporter YePEPT from Y.
enterocolitica (UniProt accession number: R9G739) was
amplified by PCR from cell lysate (provided by the Vet-
suisse Faculty, University of Bern, Bern, Switzerland)
using the forward primer 5′-AAAAGCGGCCGCAATG
CAAACCTCTACTAAC-3′ and the reverse primer 5′-
AAAACTCGAGGGCGGTTTGCTGGCC-3′. The PCR
products were digested with the restriction enzymes
NotI and XhoI, and ligated into the pZUDF21-rbs-3C-
10His expression vector, a pET21 derivative, which
produces a target protein with human rhinovirus 3C
(HRV3C) protease cleavage site and deca-His tag at the
C-terminus [19].
Protein production and purification
For overexpression, E. coli BL21(DE3) pLysS cells were
transformed with the pZUDF21-rbs-YePEPT-3C-10His
construct. A starter culture was prepared by flushing
colonies from the transformation plate into 500 mL of
LB medium supplemented with 100 μg/ml ampicillin
and then incubated at 37 °C overnight at 180 rpm in an
incubation shaker. Next, 20 l LB medium was inoculated
1:100 with the overnight culture. Overexpression was
initiated at OD600 of 0.8–1.0 by addition of 0.3 mM
isopropyl-β-D-1-thiogalactopyranoside and incubated at
20 °C for 16–20 h at 180 rpm in an incubation shaker.
Cells were harvested by centrifugation and cell pellets were
resuspended in 5 ml lysis buffer (20 mM Tris–HCl, pH
8.0, 150 mM NaCl) per gram of cells. Cells were then lysed
using a M-110P Microfluidizer (Microfluidics, Newton,
MA, USA) at 15,000 psi pressure during five passages. Cell
debris were removed by centrifugation (10,000 × g, 20 min,
4 °C). The supernatant was further subjected to ultracentri-
fugation to collect the membranes (100,000 × g, 1 h, 4 °C).
Membrane pellets were resuspended in lysis buffer and the
previous ultracentrifugation step was repeated. Membranes
from 20 l were finally resuspended in 20 ml of resuspen-
sion buffer (20 mM Tris–HCl, pH 8.0, 300 mM NaCl) and
stored as 1 ml aliquots at −80 °C.
For purification, membranes were solubilized with 2 %
(w/v) n-dodecyl-β-D-maltopyranoside (DDM) for 1 h at
4 °C under gentle agitation. Solubilized membranes were
separated from unsolubilized fractions by ultracentri-
fugation (100,000 × g, 1 h, 4 °C). The supernatant was
diluted 1:1 with binding buffer (20 mM Tris–HCl,
pH 8.0, 300 mM NaCl, 40 mM imidazole) and mixed
with Ni-NTA Superflow Beads (Qiagen, Limburg, The
Netherlands) (0.5 ml bed volume for solubilized mem-
branes from 1 l cell culture), which had been previously
equilibrated with equilibration buffer (20 mM Tris–HCl,
pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.03 % (w/v)
DDM). After 2 h of gentle rotation at 4 °C, the beads were
transferred into a column and washed with ten column
volumes of washing buffer (20 mM Tris–HCl, pH 8.0,
300 mM NaCl, 5 mM histidine, 0.03 % (w/v) DDM). The
column was then equilibrated with five column volumes of
cleavage buffer (20 mM Tris–HCl, pH 8.0, 150 mM NaCl,
0.03 % (w/v) DDM) and cleaved on-column by the addition
of 250 units of HRV3C protease (BioVision, Milpitas, CA,
USA). After incubation for 17 h at 4 °C under gentle rota-
tion, YePEPT was eluted by addition of cleavage buffer.
Crystallization
Crystallization was performed using a Mosquito robot
(TTP Labtech, Melbourn, UK). Drops of 200 nl volume
were dispensed in 96-well sitting drop plates and incu-
bated at 18 °C. Initial crystallization hits were obtained
with the MemGold (Molecular Dimensions, Newmarket,
UK) screen. Best diffracting crystals appeared after 4
days in 25 mM sodium acetate, pH 5.0, 50 mM lithium
phosphate, 50 mM lithium sulphate, 32 % PEG300 and a
protein concentration of 7 mg/ml. Crystals were har-
vested, flash-frozen in liquid nitrogen and subjected to
X-ray analysis.
Structure determination and refinement
The native data set of YePEPT was collected at the
X06SA (PXI) beamline at Swiss Light Source (SLS; Paul
Scherrer Institute, Villigen, Switzerland) and processed
with XDS [20]. Phasing by molecular replacement using
the coordinates of GkPOT [9] and the following refine-
ment steps were performed using the PHENIX package
[21]. Model building was performed using Coot [22]. All
structure figures were generated with PyMOL [23]. The
data and refinement statistics are listed in Table 1.
Uptake assay with E. coli cells
Precultures of E. coli BL21(DE3) pLysS cells containing
constructs of wild-type, K314A and K314E of YePEPT,
and empty vector (control) were inoculated 1:100 into
80 ml of LB medium with 100 μg/ml ampicillin. Cells
were grown in an incubation shaker (37 °C, 180 rpm) and
protein expression was induced at an OD600 of 0.8–1.0
with 0.3 mM isopropyl-β-D-thiogalactopyranoside. After 3
h of further incubation shaking, cells corresponding to 1
ml at an OD600 of 15 were pelleted by centrifugation
(5,000 × g, 4 °C, 15 min). Cells were then resuspended in
1.5 ml of uptake buffer (50 mM HEPES-NaOH, pH 7.5,
150 mM NaCl, 5 mM glucose). The uptake assay was per-
formed in a final volume of 50 μl per data point, which in-
cludes 20 μl of cell suspension, 10 μl of substrate Master
mix (yielding a final concentration in the assay of 50 μM
Ala-Ala spiked with [3H]Ala-Ala (Campro Scientific,
Veenendaal, The Netherlands) to a specific activity of
0.04 Ci/mmol) and 20 μl of competitor (yielding a final
concentration in the assay of 2.5 mM or 10 mM for the
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substrate chain length experiment). For Km determination
(saturation experiment) various concentrations of [3H]Ala-
Ala were used at a specific activity of 0.0016 Ci/mmol and
50 μl assay volume. In Ki determination experiments vari-
ous concentrations of Asp-Ala were used as competitor.
For Na+ dependence experiments, the 150 mM NaCl of
the buffer was replaced by 150 mM choline chloride
and for H+ dependence 50 μM carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) was included. Uptake
experiments were performed at room temperature under
gentle shaking and stopped after 100 s by adding 450 μl of
ice-cold uptake buffer. Separation of cells was performed
by centrifugation (14,000 × g, 2 min). Pellets were resus-
pended in 50 μl of 5 % (w/v) SDS and transferred to a white
96-well plate (OptiPlate, PerkinElmer, Waltham, MA,
USA). Next, 150 μl scintillation cocktail (MicroScint 40,
PerkinElmer) were added before measuring with a Packard
TopCount (PerkinElmer) scintillation counter. For Km and
Ki determinations Prism 5 (GraphPad software) was used.
Uptake assay with Xenopus oocytes
For the uptake assay, 10 ng of cRNA coding for human
PEPT1 (wild-type) or PEPT1Q300K were injected into
Xenopus laevis oocytes. Oocytes were incubated at 18 °C
for 3 days in Modified Barth’s Medium (MBM; 10 mM
HEPES-NaOH, pH 7.4, 88 mM NaCl, 1 mM KCl, 2.4 mM
NaHCO3, 0.82 mM MgSO4, 0.66 mM NaNO3, 0.75 mM
CaCl2) supplemented with 10 μg/ml of penicillin strepto-
mycin antibiotic mixture (Sigma-Aldrich, St Louis, MO,
USA). Water-injected oocytes were used as control. Up-
take experiments were performed by using pools of 15
oocytes in 2 ml Eppendorf tubes. MBM was carefully re-
moved with a pipette. To the pools of oocytes, 200 μl of
the corresponding uptake solution containing 47.5 μM
Ala-Ala spiked with 1 μCi of [3H]-Ala-Ala (Campro
Scientific; final specific activity 0.1 Ci/mmol) and 2.5 mM
of competitor (or no competitor) in MBM was added.
Mixtures were incubated at room temperature for 15 min
with intermittent gentle shaking. Uptake solution was then
removed carefully and oocytes were washed four times
with 1 ml of cold MBM. Individual oocytes were trans-
ferred into wells of a 96-well plate and 50 μl of 5 % (w/v)
SDS were added. Plates were shaken at 900 rpm (Eppen-
dorf Thermomixer) until oocytes were completely lysed
and the solution looked homogeneous. To each well 150
μl of MicroScint 40 (PerkinElmer) was added followed by
mixing (Eppendorf Thermomixer, 500 rpm, 2 min). Plates
were measured with a Packard TopCount (PerkinElmer)
scintillation counter. Data was analyzed with Prism 5
(GraphPad software).
Accession codes
Coordinates and structure factors have been deposited
in the Protein Data Bank (PDB) under ID code 4W6V.
Additional files
Additional file 1: Table S1. Conserved motifs in POT/PTR family
members and Phe-Lys region. Amino acid sequence alignment was
performed with Clustal Omega [24]. The UniProt ID codes of YePEPT,
hPEPT1 and hPEPT2 are R9G739, P46059 and Q16348, respectively. The
three characters (*, : and ·) indicate positions that have a single, fully
conserved residue (*), and conservation between groups of strongly (:)
and weakly similar properties (·). The strong and weak groups are defined
as strong score >0.5 and weak score ≤0.5 occurring in the Gonnet PAM
250 matrix. Color coding of amino acid residues is according to their
physicochemical properties, namely small and hydrophobic (including
aromatic except Tyr) (red), acidic (blue), basic (magenta), and other (green)
amino acid residues. Phe311 and Lys314 in YePEPT are highlighted in yellow
(Phe-Lys region). Short description of the three conserved motifs in POT/PTR
family members: The EFxERFxYYG motif is located on H1 and was previously
shown to play a role in proton and substrate binding [7–11]. The PTR2_1
motif spans the first cytoplasmic loop that connects H2 and H3, and its
function is currently unclear. The PTR2_2 motif is located on H5 and is part
of the intracellular gate, which plays a role in regulating the exit of peptides
from the substrate-binding site [6]. (DOC 37 kb)
Additional file 2: Figure S1. Ki determination of YePEPT for Glu-Ala.
The determined Ki is indicated (95 % confidence intervals: 28–79 μM).
Error bars represent SEM from triplicates. One of two similar independent
experiments is shown. (TIFF 64 kb)
Additional file 3: Figure S2. Electron density map from the YePEPT
crystal structure. Stereo view of the final 2 m|Fo|-D|Fc| electron density
map of YePEPT after refinement, contoured at 1.0 σ. Helix 1 is shown.
The YePEPT structure is depicted by stick models. (TIFF 4156 kb)
Additional file 4: Figure S3. Structural alignment of YePEPT with YbgH,
GkPOTE310Q, PepTSo2 and PepTSt. Core structures are displayed in blue
(YePEPT), red (YbgH), green (GkPOTE310Q), magenta (PepTSo2) and yellow
(PepTSt). RMSD values are 1.80 Å (for 342 residues; YbgH), 1.73 Å (for 391
residues; GkPOTE310Q), 1.78 Å (for 346 residues; PepTSo2) and 1.51 Å (for
336 residues; PepTSt). The HA and HB helices were omitted due to their
intrinsic flexibility and are only displayed for YePEPT (light grey). PDB ID
codes of used models: 4W6V (YePEPT); 4Q65 (YbgH); 4IKZ (GkPOTE310Q);
4LEP (PepTSo2); and 4APS (PepTSt). (TIFF 4602 kb)
Additional file 5: Figure S4. Views on the substrate binding pockets of
YePEPT, GkPOTE310Q and PepTSt. The models of the substrate-free YePEPT
and the substrate-bound GkPOTE310Q and PepTSt were aligned. For
comparison, the binding pockets are shown: YePEPT (A and D); GkPOTE310Q
(B and E); and PepTSt (C and F). The conserved residues in the binding
pockets (see Additional file 6: Table S2 for a detailed description) are
shown as black sticks and the substrates are colored in yellow (alafosfalin;
GkPOTE310Q; B and E) and green (Ala-Phe; PepTSt; C and F). In all panels the
N- and C-terminal six-helix bundles (Cα- backbones) are displayed in reddish
and bluish colors, respectively. Note that the positions of the bundles and,
most importantly, of the conserved residues are in good agreement. PDB ID
codes of used models: 4W6V (YePEPT); 4IKZ (GkPOTE310Q); and 4D2C (PepTSt).
(TIFF 5238 kb)
Additional file 6: Table S2. Groups of peptide transporter amino acid
residues involved and potentially involved in alafosfalin and Ala-Phe
dipeptide backbone binding. (DOC 37 kb)
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